Is Precipio’s share price struggling?
In the past three years, the share price of Precipio, Inc. ( NASDAQ:PRPO ) has struggled to grow and now shareholders... Precipio, Inc. announced that it has launched the HemeScreen®Anemia Panel as part of its suite of diagnostic tests.
What is the upside for Precipio's stock?
1 brokerages have issued 12 month price objectives for Precipio's stock. Their forecasts range from $7. 00 to $7. 00. On average, they expect Precipio's share price to reach $7. 00 in the next twelve months. This suggests a possible upside of 451. 2% from the stock's current price.
What happened to the CFO at Precipio?
NEW HAVEN, Conn., March 21, 2022 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced that Mr. Carl Iberger, Precipio’s CFO for the past five years, is resigning as the Chief Financial Officer effective as of today, March 21st, 2022. Mr.
Is Precipio stock up 139 percent year-to-date?
The stock is up 139 percent year-to-date and has risen 643 percent over the last year. According to MarketBeat, Precipio stock is being tracked by just one Wall Street analyst.
Are investors shorting Precipio?
Precipio saw a increase in short interest in May. As of May 15th, there was short interest totaling 569,700 shares, an increase of 79.1% from the A...
When is Precipio's next earnings date?
Precipio is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast for Precipio .
How were Precipio's earnings last quarter?
Precipio, Inc. (NASDAQ:PRPO) issued its quarterly earnings data on Thursday, August, 23rd. The biotechnology company reported ($0.15) earnings per...
When did Precipio's stock split? How did Precipio's stock split work?
Shares of Precipio reverse split before market open on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The...
Who are Precipio's key executives?
Precipio's management team includes the following people: Mr. Ilan Danieli , Founder, Pres, CEO & Director (Age 50, Pay $480.96k) ( LinkedIn Pro...
Who are some of Precipio's key competitors?
Some companies that are related to Precipio include IsoPlexis (ISO) , Accelerate Diagnostics (AXDX) , Scientific Industries (SCND) , Astrotech...
What other stocks do shareholders of Precipio own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Precipio investors own include Biocept (BIOC) , Heat Biol...
What is Precipio's stock symbol?
Precipio trades on the NASDAQ under the ticker symbol "PRPO."
Who are Precipio's major shareholders?
Precipio's stock is owned by a number of retail and institutional investors. Top institutional investors include Dimensional Fund Advisors LP (0.24...
About Precipio
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR.
Headlines
When Can We Expect A Profit From Precipio, Inc. (NASDAQ:PRPO)? - Nasdaq
Precipio (NASDAQ:PRPO) Frequently Asked Questions
1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Precipio in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Precipio stock. View analyst ratings for Precipio or view top-rated stocks.
Precipio Daily Chart Analysis
Precipio looks to have broken out of what technical traders may call a falling wedge pattern.
Key Levels To Watch
The stock has been falling the past couple of months forming into a falling wedge pattern before breaking out Monday.
What is the Precipio conference call number?
The call will include updates on all of the company’s current core businesses. The conference call may be accessed by calling 844-695-5519 (international callers dial 1-412-902-6760). All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call to ...
How long does it take to get AML results?
This means that when a patient presents with severe symptoms that cause suspicion of AML, the office can draw a blood sample and immediately proceed to test the patient for AML, with results that can potentially be obtained as rapidly as approximately 4 hours later.
When is Precipio's earnings call 2021?
NEW YORK, NY / ACCESSWIRE / May 20, 2021 / Precipio, Inc. (NASDAQ:PRPO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 20, 2021 at 5:00 PM Eastern Time.
PRPO Stock Overview
Precipio, Inc., a cancer diagnostics and reagent technology company, provides diagnostic products and services in the United States oncology market.
Valuation
Is Precipio undervalued compared to its fair value and its price relative to the market?
Future Growth
How is Precipio forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
Dividend
What is Precipio current dividend yield, its reliability and sustainability?
Management
How experienced are the management team and are they aligned to shareholders interests?
Ownership
Who are the major shareholders and have insiders been buying or selling?
What happened to Precipio stock?
Precipio stock gained 172 percent on May 3, and was up in premarket trading on May 4. The stock is up 139 percent year-to-date and has risen 643 percent over the last year.
Is Precipio stock a good investment?
Precipio generated net sales of $6.1 million in 2020, which represents a 95 percent rise from 2019. Analysts polled by TIKR expect the company’s revenue to rise 122 and 45 percent, respectively, in 2021 and 2022. Precipio stock looks like a good investment based on its growth outlook.
Should you buy Precipio stock?
Precipio's next-12-month EV-to-sales multiple is 6.5x, which looks attractive compared with that of other biotech stocks. Illumina and Agilent Technologies have multiples of 13.1x and 7.0x, respectively. Precipio stock is trading above its 50-day and 200-day moving averages, suggesting that investor sentiment is turning bullish.
